Supplementary Figure from Phase II Clinical Trial of Eribulin–Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma

Authors :: Hyo Song Kim
Jin-Hee Ahn
Sun Young Rha
Su-Jin Shin
Inkyung Jung
Yoon Woo Koh
Jee Hung Kim
Sang Kyum Kim
Yoon Dae Han
Wooyeol Baek
Seung Hyun Kim
Young Han Lee
Kum-Hee Yun
Jeong Eun Kim
Nam Suk Sim
Chang Gon Kim
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Figure from Phase II Clinical Trial of Eribulin–Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma

Full Text Access

Tools